BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29437639)

  • 1. Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI.
    Montague SJ; Delierneux C; Lecut C; Layios N; Dinsdale RJ; Lee CS; Poulter NS; Andrews RK; Hampson P; Wearn CM; Maes N; Bishop J; Bamford A; Gardiner C; Lee WM; Iqbal T; Moiemen N; Watson SP; Oury C; Harrison P; Gardiner EE
    Blood Adv; 2018 Feb; 2(3):240-251. PubMed ID: 29437639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin exposure triggers αIIbβ3-independent platelet aggregate formation, ADAM10 activity and glycoprotein VI shedding in a charge-dependent manner.
    Montague SJ; Hicks SM; Lee CS; Coupland LA; Parish CR; Lee WM; Andrews RK; Gardiner EE
    J Thromb Haemost; 2020 Jun; 18(6):1447-1458. PubMed ID: 32198957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
    Stack JR; Madigan A; Helbert L; Dunne E; Gardiner EE; Andrews RK; Finan R; Smyth E; Kenny D; McCarthy GM
    PLoS One; 2017; 12(11):e0188027. PubMed ID: 29141000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of soluble glycoprotein VI, a potential platelet activation biomarker.
    Naitoh K; Hosaka Y; Honda M; Ogawa K; Shirakawa K; Furusako S
    Platelets; 2015; 26(8):745-50. PubMed ID: 25549161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet reactivity as measured by plasma glycoprotein VI in gout.
    Conway R; Murphy CL; Madigan A; Kavanagh P; Geraghty L; Redmond N; Helbert L; Carey JJ; Dunne E; Kenny D; McCarthy GM
    Platelets; 2018 Dec; 29(8):821-826. PubMed ID: 29090618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.
    Aota T; Naitoh K; Wada H; Yamashita Y; Miyamoto N; Hasegawa M; Wakabayashi H; Yoshida K; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Nishikawa M; Katayama N; Uchida A; Sudo A
    Int J Hematol; 2014 Nov; 100(5):450-6. PubMed ID: 25253166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.
    Yamashita Y; Naitoh K; Wada H; Ikejiri M; Mastumoto T; Ohishi K; Hosaka Y; Nishikawa M; Katayama N
    Thromb Res; 2014 Mar; 133(3):440-4. PubMed ID: 24325877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke.
    Al-Tamimi M; Gardiner EE; Thom JY; Shen Y; Cooper MN; Hankey GJ; Berndt MC; Baker RI; Andrews RK
    Stroke; 2011 Feb; 42(2):498-500. PubMed ID: 21193745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation.
    Takahashi N; Usui M; Naitoh K; Wada H; Mastsui T; Kobayashi T; Matsumoto T; Uemoto S; Isaji S
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):274-281. PubMed ID: 26346441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
    Trevillyan JM; Gardiner EE; Andrews RK; Maisa A; Hearps AC; Al-Tamimi M; Crowe SM; Hoy JF
    Platelets; 2017 May; 28(3):301-304. PubMed ID: 27848272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPVI modulation during platelet activation and storage: its expression levels and ectodomain shedding compared to markers of platelet storage lesion.
    Hosseini E; Ghasemzadeh M; Nassaji F; Jamaat ZP
    Platelets; 2017 Jul; 28(5):498-508. PubMed ID: 27778530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa.
    Al-Tamimi M; Grigoriadis G; Tran H; Paul E; Servadei P; Berndt MC; Gardiner EE; Andrews RK
    Blood; 2011 Apr; 117(14):3912-20. PubMed ID: 21252089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet surface receptor glycoprotein VI-dimer is overexpressed in stroke: The Glycoprotein VI in Stroke (GYPSIE) study results.
    Induruwa I; McKinney H; Kempster C; Thomas P; Batista J; Malcor JD; Bonna A; McGee J; Bumanlag-Amis E; Rehnstrom K; Ashford S; Soejima K; Ouwehand W; Farndale R; Downes K; Warburton E; Moroi M; Jung S
    PLoS One; 2022; 17(1):e0262695. PubMed ID: 35041713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Lahu S; Adler K; Mayer K; Hein-Rothweiler R; Bernlochner I; Ndrepepa G; Schüpke S; Holdenrieder S; Bongiovanni D; Laugwitz KL; Schunkert H; Gawaz M; Massberg S; Kastrati A; Münch G
    Thromb Haemost; 2024 Apr; 124(4):297-306. PubMed ID: 37591289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
    Pennings GJ; Yong AS; Wong C; Al-Tamimi M; Gardiner EE; Andrews RK; Kritharides L
    Platelets; 2014; 25(8):639-42. PubMed ID: 24245520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation.
    Egan K; Dillon A; Dunne E; Kevane B; Galvin Z; Maguire P; Kenny D; Stewart S; Ainle FN
    J Thromb Thrombolysis; 2017 Jan; 43(1):54-59. PubMed ID: 27416950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of soluble glycoprotein VI is neither affected by animal-derived antibeta-2-glycoprotein 1 antibodies nor IgG fractions from patients with systemic lupus erythematosus.
    Ho YC; Ahuja KDK; Andrews RK; Adams MJ
    Blood Coagul Fibrinolysis; 2020 Jun; 31(4):258-263. PubMed ID: 32205472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke.
    Wurster T; Poetz O; Stellos K; Kremmer E; Melms A; Schuster A; Nagel E; Joos T; Gawaz M; Bigalke B
    Platelets; 2013; 24(7):560-5. PubMed ID: 23215725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.
    Pignatelli P; Pastori D; Bartimoccia S; Menichelli D; Vicario T; Nocella C; Carnevale R; Violi F
    Pharmacol Res; 2016 Nov; 113(Pt A):484-489. PubMed ID: 27693274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI.
    Inoue O; Osada M; Nakamura J; Kazama F; Shirai T; Tsukiji N; Sasaki T; Yokomichi H; Dohi T; Kaneko M; Kurano M; Oosawa M; Tamura S; Satoh K; Takano K; Miyauchi K; Daida H; Yatomi Y; Ozaki Y; Suzuki-Inoue K
    Int J Hematol; 2019 Sep; 110(3):285-294. PubMed ID: 31165998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.